Siemens Healthineers Archives - Page 5 of 7

The 100 largest medical device companies in the world

Nearly half a trillion dollars — $421 billion to be exact — that’s how much the world’s 100 largest medical device companies brought in over the past year amid the COVID-19 pandemic.

That’s one of the big takeaways from the Big 100, MassDevice and Medical Design & Outsourcing‘s annual analysis of the worlds’ 100 largest medtech companies. (Check out the full Big 100 rankings here.)

Aggregate revenue for approximately 100 of the largest medical technology companies dropped 1.2% in 2020 compared to 2019. But that’s not bad considering that the worst pandemic in a century was taking place, sparking a global recession in its wake.

Some medtech businesses that played critical roles fighting the pandemic — such as 3M’s Health Care segment and Hologic — even saw revenues increase and rose in the Big 100 rankings as a result.

Check out the full Big 100 rankings here>>

Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

[Image from Jp Valery on Unsplash]Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more.

Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired.

Here are the 10 biggest mergers and acquisitions in medtech in 2021:

Next>

Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

[Image from Jp Valery on Unsplash]

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more.

Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired.

Here are the 10 biggest mergers and acquisitions in medtech in 2021:

Next>>

Siemens Healthineers rises on Q4 revenue beat

Siemens Healthineers (ETR:SHL) shares ticked up today on fourth-quarter results that topped the consensus sales forecast.

The Erlangen, Germany-based company posted profits of $538 million (€466 million), or 47¢ per share, on sales of $6 billion (€5.2 billion) for the three months ended Sept. 30, 2021, for a 7.9% bottom-line gain on sales growth of 33.2%.

Adjusted to exclude one-time items, earnings per share were 61¢, 6¢ behind Wall Street, where analysts were looking for sales of $5.7 billion.

Diagnostics revenues saw the largest bump year-over-year (22.3%), even excluding $184.7 million in revenues from COVID-19 antigen tests.

“The Siemens Healthineers team successfully ended the record year 2021 with a strong quarter. We demonstrated an agile and prudent response to the pandemic,” Siemens Healthineers CEO Bernd Montag said in a news release. “We start the new fiscal year as an even more holistic and relevant healthcare compan…

Women researchers receive a fraction of funding from the world’s biggest medtech companies

The gender divide in medtech extends beyond leadership and into funding for investigational studies by U.S. physicians.

Only 6.7% of physicians who received research payments from the world’s largest medical device companies in 2020 were women, according to an analysis of Medical Design & Outsourcing’s Big 100 list of medtech companies and CMS Open Payments data.

Among the 20 medical device companies that fund research by U.S. physicians are 3M, Abbott, BD, Boston Scientific, Johnson & Johnson (dba J&J Surgical Vision and J&J Vision Care), Medtronic (dba Medtronic, Medtronic Minimed, Medtronic USA, Medtronic Vascular), Royal Philips (dba Philips Electronics), Stryker and Zimmer Biomet.

Together, those companies paid $3.9 million to 312 doctors in 2020, but only 21 were women, receiving a collective $402,600.

Women physicians, on average, received 15.7% of payments from each of the top medtech companies, but accounted f…

FDA clears ‘major’ CT advance out of Siemens Healthineers

FDA announced today that it has cleared Siemens Healthineers’ Naeotom Alpha, describing the device as the first major computed tomography advancement in nearly a decade.

The Naeotom Alpha uses the emerging CT technology of photon-counting detectors. The sensors measure each X-ray that passes through a person’s body. Previously, CT detectors have measured the total energy contained in many X-rays at once.

“Counting” each individual X-ray photon enables more detailed 3D imagery about what is going on inside a patient.

FDA official Laurel Burk noted in an FDA news release that computed tomography is an important medical imaging tool that can aid in diagnosing disease, trauma or abnormality. CT also aids in the planning and guiding of interventional or therapeutic procedures, as well as monitoring the effectiveness of certain therapies.

“Today’s action represents the first major new technology for computed tomograph…

Siemens Healthineers wins FDA clearance for Magnetom Free.Max MR scanner

Siemens Healthineers (ETR:SHL) announced today that it received FDA clearance for the Magnetom Free.Max magnetic resonance (MR) scanner.

Malvern, Pa.-based Siemens Healthineers developed the High-V MR scanner to combine a 0.55 Tesla field strength with deep learning technologies and advanced image processing to broaden the range of MR clinical applications, according to a news release.

The company touts the Magnetom Free.Max as the first and only 80 cm wide-bore system available, while the platform also facilitates MR scanning for extremely obese and claustrophobic patients.

Siemens Healthineers said that, at 3.5 tons and less than 80 inches tall, the MR scanner is the “most lightweight, compact whole-body scanner” the company has ever offered, with the reduced size permitting installation with minimal structural modifications. It uses less than 1 liter of helium, compared to the standard of several hundred liters, the company added.

T…

Varian wins FDA breakthrough nod for cardiac radioablation system

Varian announced today that it received FDA breakthrough device designation for its cardiac radioablation (CRA) system.

Palo Alto, Calif.-based Varian, a recently acquired Siemens Healthineers company, developed the CRA system as a noninvasive therapy for select patients with refractory ventricular tachycardia (VT), according to a news release.

VT, a fast, abnormal heart rate that could lead to sudden cardiac arrest, can be treated with an implantable cardioverter-defibrillator (ICD), antiarrhythmic medications or an invasive catheter ablation procedure. Still, Varian says those methods are often insufficient in controlling VT.

The Varian CRA system won the breakthrough nod because it could offer a more effective treatment for refractory VT through the noninvasive targeting and delivery of ablative energy across the full thickness of the myocardium, unlike conventional catheter ablation.

Varian believes that if the planned clinical studies support…

MedTech 100 roundup: Largest slide for industry in 2021

The medtech industry’s 2021 performance has been all over the place and the past weekend highlighted its topsy-turvy nature.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — had been on the rise since the beginning of April, with its mark of 112.25 on April 16 representing an all-time best, topping the previous high of 110.96 set on Feb. 15.

Just one week later, the index topped itself again, reaching 114.58 to end the week on April 23, marking an increase of 2.1% from the previous week.

After a -1.6% decrease over the week ending on April 30, there was little indication of in which direction the index would head next. The industry’s response to the slight dip was an even sharper downturn with a 4.49-point loss.

On May 6, the index finished the day at 108.21, representing a -4% slide from the previous week’s mark and a -5.6% fall from the high-point set the previous week. Th…

Siemens Healthineers ticks up on Q2 earnings, raised guidance

Siemens Healthineers (ETR:SHL) shares ticked up today on strong second-quarter results and raised guidance for 2021.

The Erlangen, Germany-based company posted profits of $539 million (€447 million), or 50¢ per share, on sales of $4.8 billion for the three months ended March 31, 2021, for an 8% bottom-line gain on sales growth of 7.6%.

Adjusted to exclude one-time items, earnings per share were 53¢ for the company that earlier this month completed a massive $16.4 billion purchase of Varian Medical Systems.

Siemens Healthineers’ diagnostics business was a major growth driver, with sales rising 29.1% year-over-year amid high demand for the company’s rapid COVID-19 antigen tests, according to a news release.

Additionally, the company’s imaging business saw revenue growth of 7.4% in imaging and sales numbers grew 2% in advanced therapies.

“The Siemens Healthineers team has done an outstanding job during the past months. …

MedTech 100 roundup: Industry skies to all-time high

The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen.

MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to end the week before last (April 9). Having only set its previous all-time best of 110.96 on Feb. 15, the industry’s topsy-turvy run gave no indication of which direction it was heading next.

However, after the rise over the past couple of weeks, the industry rode that wave to a new all-time high of 112.25 to end last week on April 16. That represents a 2.6% rise from the previous week’s tally.

Improvements continue to shine a light on the strong position the industry has settled into a year on from the height of the COVID-19 pandemic’s impact on medtech, as the industry has produced an 21.6% rise from the pre-pandemic high of 92.32 (set on Feb. 1…

DTW Podcast: How is Zimmer Biomet waging the ortho data war? Do medical devices carry physics-based biases?

This week’s DeviceTalks Weekly Podcast guests

In this week’s DeviceTalks Weekly Podcast, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics.

Teplitsky, an engineer who built her medtech career in cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZB edge suite of digital and robotics technologies.

In a separate interview, we talk with Achuta Kadambi, assistant professor at the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races.

Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future.

See our initial report in Medical Design and Outsourcing here.

Chris New…